naltrexone and n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide

naltrexone has been researched along with n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corley, G; Rawls, SM1
Hiramoto, K; Yamate, Y; Yokoyama, S1

Other Studies

2 other study(ies) available for naltrexone and n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide

ArticleYear
Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 92, Issue:3

    Topics: Acetaminophen; Aminoquinolines; Animals; Benzamides; Body Temperature; Hypothermia, Induced; Male; Naltrexone; Nociceptin Receptor; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant

2009
Ultraviolet A eye irradiation ameliorates colon carcinoma induced by azoxymethane and dextran sodium sulfate through β-endorphin and methionine-enkephalin.
    Photodermatology, photoimmunology & photomedicine, 2017, Volume: 33, Issue:2

    Topics: Aminoquinolines; Animals; Azoxymethane; Benzamides; beta-Endorphin; Colon; Colonic Neoplasms; Dextran Sulfate; Enkephalin, Methionine; Eye; Female; Interleukin-6; Ki-67 Antigen; Mice, Inbred ICR; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Tumor Necrosis Factor-alpha; Ultraviolet Rays

2017